Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) ICAD (Intracranial Atherosclerotic Disease) Pathology Market 2018, Forecast to 2023

Publisher Name :
Date: 07-Aug-2018
No. of pages: 129

Intracranial atherosclerotic disease is the progressive narrowing of the cerebral arteries within the skull (intracranial). The arteries that supply oxygen-enriched blood to the brain are the carotid arteries and the vertebral arteries. The circle of Willis is the area at the base of the brain that joins these arteries.

Scope of the Report:

This report focuses on the ICAD (Intracranial Atherosclerotic Disease) Pathology in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

The classification of ICAD (Intracranial Atherosclerotic Disease) Pathology includes Stent and PTA Balloon, and the proportion of Stent in 2017 is about 80.15%.

ICAD (Intracranial Atherosclerotic Disease) Pathology is widely used in Hospital, Clinic and other field. The most proportion of ICAD (Intracranial Atherosclerotic Disease) Pathology is Hospital, and the consumption proportion in 2017 is about 63%.

North America is the largest Sales place, with a Sales market share nearly 26% in 2017. Following North America, Europe is the second largest Sales place with the Sales market share of 20%.

Market competition is intense. Stryker, Balt, TERUMO, MicroPort, Acandis, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.

The worldwide market for ICAD (Intracranial Atherosclerotic Disease) Pathology is expected to grow at a CAGR of roughly 8.7% over the next five years, will reach 220 million US$ in 2023, from 130 million US$ in 2017, according to a new GIR (Global Info Research) study.

Market Segment by Manufacturers, this report covers

- Stryker

- Balt

- TERUMO

- MicroPort

- Acandis

Market Segment by Regions, regional analysis covers

- North America (United States, Canada and Mexico)

- Europe (Germany, France, UK, Russia and Italy)

- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

- South America (Brazil, Argentina, Colombia etc.)

- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

- primarily split into

- Stent

- PTA Balloon

Market Segment by Applications, can be divided into

- Hospital

- Clinic

- Other

There are 15 Chapters to deeply display the global ICAD (Intracranial Atherosclerotic Disease) Pathology market.

Chapter 1, to describe ICAD (Intracranial Atherosclerotic Disease) Pathology Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of ICAD (Intracranial Atherosclerotic Disease) Pathology, with sales, revenue, and price of ICAD (Intracranial Atherosclerotic Disease) Pathology, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of ICAD (Intracranial Atherosclerotic Disease) Pathology, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, ICAD (Intracranial Atherosclerotic Disease) Pathology market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe ICAD (Intracranial Atherosclerotic Disease) Pathology sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) ICAD (Intracranial Atherosclerotic Disease) Pathology Market 2018, Forecast to 2023

Table of Contents

1 Market Overview
1.1 ICAD (Intracranial Atherosclerotic Disease) Pathology Introduction
1.2 Market Analysis by Type
1.2.1 primarily split into
1.2.2 Stent
1.2.3 PTA Balloon
1.3 Market Analysis by Applications
1.3.1 Hospital
1.3.2 Clinic
1.3.3 Other
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Stryker
2.1.1 Business Overview
2.1.1.1 Stryker Description
2.1.1.2 Stryker Headquarter, Main Business and Finance Overview
2.1.2 Stryker ICAD (Intracranial Atherosclerotic Disease) Pathology Product Introduction
2.1.2.1 ICAD (Intracranial Atherosclerotic Disease) Pathology Production Bases, Sales Regions and Major Competitors
2.1.2.2 ICAD (Intracranial Atherosclerotic Disease) Pathology Product Information
2.1.3 Stryker ICAD (Intracranial Atherosclerotic Disease) Pathology Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.1.3.1 Stryker ICAD (Intracranial Atherosclerotic Disease) Pathology Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.1.3.2 Global Stryker ICAD (Intracranial Atherosclerotic Disease) Pathology Market Share in 2017
2.2 Balt
2.2.1 Business Overview
2.2.1.1 Balt Description
2.2.1.2 Balt Headquarter, Main Business and Finance Overview
2.2.2 Balt ICAD (Intracranial Atherosclerotic Disease) Pathology Product Introduction
2.2.2.1 ICAD (Intracranial Atherosclerotic Disease) Pathology Production Bases, Sales Regions and Major Competitors
2.2.2.2 ICAD (Intracranial Atherosclerotic Disease) Pathology Product Information
2.2.3 Balt ICAD (Intracranial Atherosclerotic Disease) Pathology Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2.3.1 Balt ICAD (Intracranial Atherosclerotic Disease) Pathology Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2.3.2 Global Balt ICAD (Intracranial Atherosclerotic Disease) Pathology Market Share in 2017
2.3 TERUMO
2.3.1 Business Overview
2.3.1.1 TERUMO Description
2.3.1.2 TERUMO Headquarter, Main Business and Finance Overview
2.3.2 TERUMO ICAD (Intracranial Atherosclerotic Disease) Pathology Product Introduction
2.3.2.1 ICAD (Intracranial Atherosclerotic Disease) Pathology Production Bases, Sales Regions and Major Competitors
2.3.2.2 ICAD (Intracranial Atherosclerotic Disease) Pathology Product Information
2.3.3 TERUMO ICAD (Intracranial Atherosclerotic Disease) Pathology Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3.3.1 TERUMO ICAD (Intracranial Atherosclerotic Disease) Pathology Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3.3.2 Global TERUMO ICAD (Intracranial Atherosclerotic Disease) Pathology Market Share in 2017
2.4 MicroPort
2.4.1 Business Overview
2.4.1.1 MicroPort Description
2.4.1.2 MicroPort Headquarter, Main Business and Finance Overview
2.4.2 MicroPort ICAD (Intracranial Atherosclerotic Disease) Pathology Product Introduction
2.4.2.1 ICAD (Intracranial Atherosclerotic Disease) Pathology Production Bases, Sales Regions and Major Competitors
2.4.2.2 ICAD (Intracranial Atherosclerotic Disease) Pathology Product Information
2.4.3 MicroPort ICAD (Intracranial Atherosclerotic Disease) Pathology Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4.3.1 MicroPort ICAD (Intracranial Atherosclerotic Disease) Pathology Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4.3.2 Global MicroPort ICAD (Intracranial Atherosclerotic Disease) Pathology Market Share in 2017
2.5 Acandis
2.5.1 Business Overview
2.5.1.1 Acandis Description
2.5.1.2 Acandis Headquarter, Main Business and Finance Overview
2.5.2 Acandis ICAD (Intracranial Atherosclerotic Disease) Pathology Product Introduction
2.5.2.1 ICAD (Intracranial Atherosclerotic Disease) Pathology Production Bases, Sales Regions and Major Competitors
2.5.2.2 ICAD (Intracranial Atherosclerotic Disease) Pathology Product Information
2.5.3 Acandis ICAD (Intracranial Atherosclerotic Disease) Pathology Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5.3.1 Acandis ICAD (Intracranial Atherosclerotic Disease) Pathology Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5.3.2 Global Acandis ICAD (Intracranial Atherosclerotic Disease) Pathology Market Share in 2017
3 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Competition, by Manufacturer
3.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales and Market Share by Manufacturer (2016-2017)
3.2 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue and Market Share by Manufacturer (2016-2017)
3.3 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Price by Manufacturer (2016-2017)
3.4 Market Concentration Rate
3.4.1 Top 3 ICAD (Intracranial Atherosclerotic Disease) Pathology Manufacturer Market Share in 2017
3.4.2 Top 5 ICAD (Intracranial Atherosclerotic Disease) Pathology Manufacturer Market Share in 2017
3.5 Market Competition Trend
4 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Analysis by Regions
4.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales, Revenue and Market Share by Regions
4.1.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Regions (2013-2018)
4.1.2 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Regions (2013-2018)
4.2 North America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales, Revenue and Growth Rate (2013-2018)
4.3 Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Sales, Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Sales, Revenue and Growth Rate (2013-2018)
4.5 South America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales, Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Sales, Revenue and Growth Rate (2013-2018)
5 North America ICAD (Intracranial Atherosclerotic Disease) Pathology by Countries, Type, Application and Manufacturers
5.1 North America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales, Revenue and Market Share by Countries
5.1.1 North America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Countries (2013-2018)
5.1.2 North America ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Countries (2013-2018)
5.1.3 United States ICAD (Intracranial Atherosclerotic Disease) Pathology Sales and Growth Rate (2013-2018)
5.1.4 Canada ICAD (Intracranial Atherosclerotic Disease) Pathology Sales and Growth Rate (2013-2018)
5.1.5 Mexico ICAD (Intracranial Atherosclerotic Disease) Pathology Sales and Growth Rate (2013-2018)
5.2 North America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales and Revenue (Value) by Manufacturers (2016-2017)
5.2.1 North America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Manufacturers (2016-2017)
5.2.2 North America ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Manufacturers (2016-2017)
5.3 North America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales, Revenue and Market Share by Type (2013-2018)
5.3.1 North America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales and Sales Share by Type (2013-2018)
5.3.2 North America ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue and Revenue Share by Type (2013-2018)
5.4 North America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales, Revenue and Market Share by Application (2013-2018)
5.4.1 North America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales and Sales Share by Application (2013-2018)
5.4.2 North America ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue and Revenue Share by Application (2013-2018)
6 Europe ICAD (Intracranial Atherosclerotic Disease) Pathology by Countries, Type, Application and Manufacturers
6.1 Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Sales, Revenue and Market Share by Countries
6.1.1 Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Countries (2013-2018)
6.1.2 Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Countries (2013-2018)
6.1.3 Germany ICAD (Intracranial Atherosclerotic Disease) Pathology Sales and Growth Rate (2013-2018)
6.1.4 UK ICAD (Intracranial Atherosclerotic Disease) Pathology Sales and Growth Rate (2013-2018)
6.1.5 France ICAD (Intracranial Atherosclerotic Disease) Pathology Sales and Growth Rate (2013-2018)
6.1.6 Russia ICAD (Intracranial Atherosclerotic Disease) Pathology Sales and Growth Rate (2013-2018)
6.1.7 Italy ICAD (Intracranial Atherosclerotic Disease) Pathology Sales and Growth Rate (2013-2018)
6.2 Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Sales and Revenue (Value) by Manufacturers (2016-2017)
6.2.1 Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Manufacturers (2016-2017)
6.2.2 Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Manufacturers (2016-2017)
6.3 Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Sales, Revenue and Market Share by Type (2013-2018)
6.3.1 Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Sales and Sales Share by Type (2013-2018)
6.3.2 Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue and Revenue Share by Type (2013-2018)
6.4 Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Sales, Revenue and Market Share by Application (2013-2018)
6.4.1 Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Sales and Sales Share by Application (2013-2018)
6.4.2 Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue and Revenue Share by Application (2013-2018)
7 Asia-Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology by Countries, Type, Application and Manufacturers
7.1 Asia-Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Countries (2013-2018)
7.1.2 Asia-Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Countries (2013-2018)
7.1.3 China ICAD (Intracranial Atherosclerotic Disease) Pathology Sales and Growth Rate (2013-2018)
7.1.4 Japan ICAD (Intracranial Atherosclerotic Disease) Pathology Sales and Growth Rate (2013-2018)
7.1.5 Korea ICAD (Intracranial Atherosclerotic Disease) Pathology Sales and Growth Rate (2013-2018)
7.1.6 India ICAD (Intracranial Atherosclerotic Disease) Pathology Sales and Growth Rate (2013-2018)
7.1.7 Southeast Asia ICAD (Intracranial Atherosclerotic Disease) Pathology Sales and Growth Rate (2013-2018)
7.2 Asia-Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Sales and Revenue (Value) by Manufacturers (2016-2017)
7.2.1 Asia-Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Manufacturers (2016-2017)
7.2.2 Asia-Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Manufacturers (2016-2017)
7.3 Asia-Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Sales, Revenue and Market Share by Type (2013-2018)
7.3.1 Asia-Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Sales and Sales Share by Type (2013-2018)
7.3.2 Asia-Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue and Revenue Share by Type (2013-2018)
7.4 Asia-Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Sales, Revenue and Market Share by Application (2013-2018)
7.4.1 Asia-Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Sales and Sales Share by Application (2013-2018)
7.4.2 Asia-Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue and Revenue Share by Application (2013-2018)
8 South America ICAD (Intracranial Atherosclerotic Disease) Pathology by Countries, Type, Application and Manufacturers
8.1 South America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales, Revenue and Market Share by Countries
8.1.1 South America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Countries (2013-2018)
8.1.2 South America ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Countries (2013-2018)
8.1.3 Brazil ICAD (Intracranial Atherosclerotic Disease) Pathology Sales and Growth Rate (2013-2018)
8.1.4 Argentina ICAD (Intracranial Atherosclerotic Disease) Pathology Sales and Growth Rate (2013-2018)
8.1.5 Colombia ICAD (Intracranial Atherosclerotic Disease) Pathology Sales and Growth Rate (2013-2018)
8.2 South America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales and Revenue (Value) by Manufacturers (2016-2017)
8.2.1 South America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Manufacturers (2016-2017)
8.2.2 South America ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Manufacturers (2016-2017)
8.3 South America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales, Revenue and Market Share by Type (2013-2018)
8.3.1 South America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales and Sales Share by Type (2013-2018)
8.3.2 South America ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue and Revenue Share by Type (2013-2018)
8.4 South America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales, Revenue and Market Share by Application (2013-2018)
8.4.1 South America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales and Sales Share by Application (2013-2018)
8.4.2 South America ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue and Revenue Share by Application (2013-2018)
9 Middle East and Africa ICAD (Intracranial Atherosclerotic Disease) Pathology by Countries, Type, Application and Manufacturers
9.1 Middle East and Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Countries (2013-2018)
9.1.2 Middle East and Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Countries (2013-2018)
9.1.3 Saudi Arabia ICAD (Intracranial Atherosclerotic Disease) Pathology Sales and Growth Rate (2013-2018)
9.1.4 UAE ICAD (Intracranial Atherosclerotic Disease) Pathology Sales and Growth Rate (2013-2018)
9.1.5 Egypt ICAD (Intracranial Atherosclerotic Disease) Pathology Sales and Growth Rate (2013-2018)
9.1.6 Nigeria ICAD (Intracranial Atherosclerotic Disease) Pathology Sales and Growth Rate (2013-2018)
9.1.7 South Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Sales and Growth Rate (2013-2018)
9.2 Middle East and Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Sales and Revenue (Value) by Manufacturers (2016-2017)
9.2.1 Middle East and Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Manufacturers (2016-2017)
9.2.2 Middle East and Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Manufacturers (2016-2017)
9.3 Middle East and Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Sales, Revenue and Market Share by Type (2013-2018)
9.3.1 Middle East and Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Sales and Sales Share by Type (2013-2018)
9.3.1 Middle East and Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue and Revenue Share by Type (2013-2018)
9.4 Middle East and Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Sales, Revenue and Market Share by Application (2013-2018)
9.4.1 Middle East and Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Sales and Sales Share by Application (2013-2018)
9.4.2 Middle East and Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue and Revenue Share by Application (2013-2018)
10 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Segment by Type
10.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales and Market Share by Type (2013-2018)
10.1.2 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue and Market Share by Type (2013-2018)
10.2 primarily split into Sales Growth and Price
10.2.1 Global primarily split into Sales Growth (2013-2018)
10.2.2 Global primarily split into Price (2013-2018)
10.3 Stent Sales Growth and Price
10.3.1 Global Stent Sales Growth (2013-2018)
10.3.2 Global Stent Price (2013-2018)
10.4 PTA Balloon Sales Growth and Price
10.4.1 Global PTA Balloon Sales Growth (2013-2018)
10.4.2 Global PTA Balloon Price (2013-2018)
11 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Segment by Application
11.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Application (2013-2018)
11.2 Hospital Sales Growth (2013-2018)
11.3 Clinic Sales Growth (2013-2018)
11.4 Other Sales Growth (2013-2018)
12 ICAD (Intracranial Atherosclerotic Disease) Pathology Market Forecast (2018-2023)
12.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales, Revenue and Growth Rate (2018-2023)
12.2 ICAD (Intracranial Atherosclerotic Disease) Pathology Market Forecast by Regions (2018-2023)
12.2.1 North America ICAD (Intracranial Atherosclerotic Disease) Pathology Market Forecast (2018-2023)
12.2.2 Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Market Forecast (2018-2023)
12.2.3 Asia-Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Market Forecast (2018-2023)
12.2.4 South America ICAD (Intracranial Atherosclerotic Disease) Pathology Market Forecast (2018-2023)
12.2.5 Middle East and Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Market Forecast (2018-2023)
12.3 ICAD (Intracranial Atherosclerotic Disease) Pathology Market Forecast by Type (2018-2023)
12.3.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Forecast by Type (2018-2023)
12.3.2 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Share Forecast by Type (2018-2023)
12.4 ICAD (Intracranial Atherosclerotic Disease) Pathology Market Forecast by Application (2018-2023)
12.4.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Forecast by Application (2018-2023)
12.4.2 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source

List of Tables and Figures

Figure ICAD (Intracranial Atherosclerotic Disease) Pathology Picture
Table Product Specifications of ICAD (Intracranial Atherosclerotic Disease) Pathology
Figure Global ICAD (Intracranial Atherosclerotic Disease) Pathology CAGR (%), Y-o-Y Growth (&) and Market Size, 2013-2023 (USD Million)
Figure Global ICAD (Intracranial Atherosclerotic Disease) Pathology CAGR (%), Y-o-Y Growth (&) and Market Size, 2013-2023 (Sales)
Figure Global Sales Market Share of ICAD (Intracranial Atherosclerotic Disease) Pathology by Types in 2017
Figure primarily split into Picture
Table Major Manufacturers of primarily split into
Figure Stent Picture
Table Major Manufacturers of Stent
Figure PTA Balloon Picture
Table Major Manufacturers of PTA Balloon
Figure ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Applications in 2017
Figure Hospital Picture
Figure Clinic Picture
Figure Other Picture
Figure United States ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue (Value) and Growth Rate (2013-2023)
Figure Canada ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue (Value) and Growth Rate (2013-2023)
Figure Mexico ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue (Value) and Growth Rate (2013-2023)
Figure Germany ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue (Value) and Growth Rate (2013-2023)
Figure France ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue (Value) and Growth Rate (2013-2023)
Figure UK ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue (Value) and Growth Rate (2013-2023)
Figure Russia ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue (Value) and Growth Rate (2013-2023)
Figure Italy ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue (Value) and Growth Rate (2013-2023)
Figure China ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue (Value) and Growth Rate (2013-2023)
Figure Japan ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue (Value) and Growth Rate (2013-2023)
Figure Korea ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue (Value) and Growth Rate (2013-2023)
Figure India ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue (Value) and Growth Rate (2013-2023)
Figure Southeast Asia ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue (Value) and Growth Rate (2013-2023)
Figure Brazil ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue (Value) and Growth Rate (2013-2023)
Figure Egypt ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue (Value) and Growth Rate (2013-2023)
Figure Saudi Arabia ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue (Value) and Growth Rate (2013-2023)
Figure South Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue (Value) and Growth Rate (2013-2023)
Figure Nigeria ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue (Value) and Growth Rate (2013-2023)
Table Stryker Headquarter, Established, Main Business and Finance Overview (2017)
Table Stryker ICAD (Intracranial Atherosclerotic Disease) Pathology Production Bases, Sales Regions and Major Competitors
Table Stryker ICAD (Intracranial Atherosclerotic Disease) Pathology Product
Table Stryker ICAD (Intracranial Atherosclerotic Disease) Pathology Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Stryker ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share in 2017
Figure Global Stryker ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share in 2017
Table Balt Headquarter, Established, Main Business and Finance Overview (2017)
Table Balt ICAD (Intracranial Atherosclerotic Disease) Pathology Production Bases, Sales Regions and Major Competitors
Table Balt ICAD (Intracranial Atherosclerotic Disease) Pathology Product
Table Balt ICAD (Intracranial Atherosclerotic Disease) Pathology Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Balt ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share in 2017
Figure Global Balt ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share in 2017
Table TERUMO Headquarter, Established, Main Business and Finance Overview (2017)
Table TERUMO ICAD (Intracranial Atherosclerotic Disease) Pathology Production Bases, Sales Regions and Major Competitors
Table TERUMO ICAD (Intracranial Atherosclerotic Disease) Pathology Product
Table TERUMO ICAD (Intracranial Atherosclerotic Disease) Pathology Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global TERUMO ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share in 2017
Figure Global TERUMO ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share in 2017
Table MicroPort Headquarter, Established, Main Business and Finance Overview (2017)
Table MicroPort ICAD (Intracranial Atherosclerotic Disease) Pathology Production Bases, Sales Regions and Major Competitors
Table MicroPort ICAD (Intracranial Atherosclerotic Disease) Pathology Product
Table MicroPort ICAD (Intracranial Atherosclerotic Disease) Pathology Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global MicroPort ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share in 2017
Figure Global MicroPort ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share in 2017
Table Acandis Headquarter, Established, Main Business and Finance Overview (2017)
Table Acandis ICAD (Intracranial Atherosclerotic Disease) Pathology Production Bases, Sales Regions and Major Competitors
Table Acandis ICAD (Intracranial Atherosclerotic Disease) Pathology Product
Table Acandis ICAD (Intracranial Atherosclerotic Disease) Pathology Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Acandis ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share in 2017
Figure Global Acandis ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share in 2017
Table Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Manufacturer (2016-2017)
Figure Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Manufacturer in 2016
Figure Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Manufacturer in 2017
Table Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Manufacturer (2016-2017)
Figure Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share by Manufacturer in 2016
Figure Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share by Manufacturer in 2017
Table Global ICAD (Intracranial Atherosclerotic Disease) Pathology Price by Manufacturer (2016-2017)
Figure Top 3 ICAD (Intracranial Atherosclerotic Disease) Pathology Manufacturer (Revenue) Market Share in 2017
Figure Top 6 ICAD (Intracranial Atherosclerotic Disease) Pathology Manufacturer (Revenue) Market Share in 2017
Figure Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales and Growth Rate (2013-2018)
Figure Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue and Growth Rate (2013-2018)
Table Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Regions (2013-2018)
Table Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Regions (2013-2018)
Table Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Regions (2013-2018)
Figure Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share by Regions in 2013
Figure Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share by Regions in 2017
Figure North America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales and Growth Rate (2013-2018)
Figure North America ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue and Growth Rate (2013-2018)
Figure Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Sales and Growth Rate (2013-2018)
Figure Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue and Growth Rate (2013-2018)
Figure Asia-Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Sales and Growth Rate (2013-2018)
Figure Asia-Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue and Growth Rate (2013-2018)
Figure South America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales and Growth Rate (2013-2018)
Figure South America ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue and Growth Rate (2013-2018)
Figure Middle East and Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Sales and Growth Rate (2013-2018)
Figure Middle East and Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue and Growth Rate (2013-2018)
Figure North America ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue and Growth Rate (2013-2018)
Table North America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Countries (2013-2018)
Table North America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Countries (2013-2018)
Figure North America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Countries in 2013
Figure North America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Countries in 2017
Table North America ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Countries (2013-2018)
Table North America ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share by Countries (2013-2018)
Figure North America ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share by Countries in 2013
Figure North America ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share by Countries in 2017
Figure United States ICAD (Intracranial Atherosclerotic Disease) Pathology Sales and Growth Rate (2013-2018)
Figure Canada ICAD (Intracranial Atherosclerotic Disease) Pathology Sales and Growth Rate (2013-2018)
Figure Mexico ICAD (Intracranial Atherosclerotic Disease) Pathology Sales and Growth Rate (2013-2018)
Table North America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Manufacturer (2016-2017)
Figure North America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Manufacturer in 2016
Figure North America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Manufacturer in 2017
Table North America ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Manufacturer (2016-2017)
Figure North America ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share by Manufacturer in 2016
Figure North America ICAD (Intracranial Atheroscle
  • Global Cardiac Equipments Market Insights, Forecast to 2025
    Published: 13-Nov-2018        Price: US 4900 Onwards        Pages: 119
    This report studies the global market size of Cardiac Equipments in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Cardiac Equipments in these regions. This research report categorizes the global Cardiac Equipments market by top players/brands, region, type and end user. This report also studies the global Cardiac Equipments market status, competition landscape, market share, growth rate, future......
  • Lateral Flow Assay Market by Application (Clinical Testing (Pregnancy, Infectious Disease (Mosquito , Influenza, STI, Hepatitis, TB), Cardiac Marker, Lipid Test) Veterinary, Food Safety) Product (Reader, Kits) Technique, End User - Global Forecast to 2023
    Published: 13-Nov-2018        Price: US 5650 Onwards        Pages: 288
    “The global lateral flow assay market projected to grow at a CAGR of 7.7%.” The global lateral flow assay market is projected to reach USD 8.7 billion by 2023 from USD 6.0 billion in 2018 growing at a CAGR of 7.7% from 2018 to 2023. Factor such as the high prevalence of infectious diseases across the globe, rapidly increasing geriatric population, increasing usage of home-based lateral flow assay devices, and growing demand for point-of-care testing are fu......
  • Global Algometer Market Insights, Forecast to 2025
    Published: 13-Nov-2018        Price: US 4900 Onwards        Pages: 116
    Algometer is software-based computerized Algometer to offer real-time visual and auditory feedback to control and monitor applied pressure rates. The global Algometer market is valued at xx million US$ in 2017 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2018-2025. The objectives of this study are to define, segment, and project the size of the Algometer market based on company, product type, end user and key regions. This report studies......
  • Global Plethysmometer Market Insights, Forecast to 2025
    Published: 13-Nov-2018        Price: US 4900 Onwards        Pages: 117
    Plethysmometer is designed to provide a highly useful tool in the measurement of small volume changes. This test is typically used to follow the evolution of the inflammatory response experimentally induced in rodents and to screen potential anti-inflammatory or anti-oedema properties of pharmacological substances. The global Plethysmometer market is valued at xx million US$ in 2017 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2018-2025. The objective......
  • Global Deep Hyperthermia Device Market Insights, Forecast to 2025
    Published: 13-Nov-2018        Price: US 4900 Onwards        Pages: 108
    This report studies the global market size of Deep Hyperthermia Device in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Deep Hyperthermia Device in these regions. This research report categorizes the global Deep Hyperthermia Device market by top players/brands, region, type and end user. This report also studies the global Deep Hyperthermia Device market status, competition landscape, market sh......
  • Global Sterilization Container Market Insights, Forecast to 2025
    Published: 13-Nov-2018        Price: US 4900 Onwards        Pages: 99
    This report presents the worldwide Sterilization Container market size (value, production and consumption), splits the breakdown (data status 2013-2018 and forecast to 2025), by manufacturers, region, type and application. This study also analyzes the market status, market share, growth rate, future trends, market drivers, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis. The Sterilization Container marke......
  • Global Veterinary Imaging Equipments Market Insights, Forecast to 2025
    Published: 13-Nov-2018        Price: US 4900 Onwards        Pages: 98
    This report studies the global market size of Veterinary Imaging Equipments in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Veterinary Imaging Equipments in these regions. This research report categorizes the global Veterinary Imaging Equipments market by top players/brands, region, type and end user. This report also studies the global Veterinary Imaging Equipments market status, competition ......
  • Global Wrist Blood Pressure Monitor Market Insights, Forecast to 2025
    Published: 13-Nov-2018        Price: US 4900 Onwards        Pages: 99
    This report studies the global market size of Wrist Blood Pressure Monitor in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Wrist Blood Pressure Monitor in these regions. This research report categorizes the global Wrist Blood Pressure Monitor market by top players/brands, region, type and end user. This report also studies the global Wrist Blood Pressure Monitor market status, competition land......
  • Global Wound Irrigation Devices Market Insights, Forecast to 2025
    Published: 13-Nov-2018        Price: US 4900 Onwards        Pages: 95
    This report studies the global market size of Wound Irrigation Devices in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Wound Irrigation Devices in these regions. This research report categorizes the global Wound Irrigation Devices market by top players/brands, region, type and end user. This report also studies the global Wound Irrigation Devices market status, competition landscape, market sh......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs